Perrigo (PRGO) Free Cash Flow (2013 - 2026)
Perrigo (PRGO) posted quarterly Free Cash Flow of -$127.4 million for Q1 2026, down 41.56% year-over-year from -$218.0 million in Q1 2025, and down 185.73% quarter-over-quarter from $148.6 million in Q4 2025.
Perrigo (PRGO) Free Cash Flow (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Free Cash Flow for 14 consecutive years, with -$127.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow fell 41.56% year-over-year to -$127.4 million; the TTM figure through Mar 2026 stood at $107.7 million (down 40.53% YoY), while the FY2025 annual figure was $145.1 million, down 40.68% from the prior year.
- Free Cash Flow retreated to -$127.4 million in Q1 2026 per PRGO's latest filing, from $148.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $274.9 million in Q4 2024 and bottomed at -$127.4 million in Q1 2026.
- Historically, Free Cash Flow has averaged $45.7 million across 5 years, with a median of $32.9 million in 2023.
- Annual changes were most pronounced in 2024 — Free Cash Flow tumbled 597.37% — and 2025, when it surged 400.0%.
- Perrigo's Free Cash Flow stood at $99.8 million in 2022, then jumped by 82.36% to $182.0 million in 2023, then soared by 51.04% to $274.9 million in 2024, then slumped by 45.94% to $148.6 million in 2025, then slumped by 185.73% to -$127.4 million in 2026.
- Business Quant data shows PRGO's Free Cash Flow at -$127.4 million in Q1 2026, $148.6 million in Q4 2025, and $29.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Perrigo | 1.98 Bn | 1.58 Bn | 313.90 Mn | 68.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 68.30 Mn |
| Jun 27, 2026 | 68.30 Mn |
| Mar 28, 2026 | -127.40 Mn |
| Mar 28, 2026 | -127.40 Mn |
| Dec 31, 2025 | 148.60 Mn |
| Dec 31, 2025 | 148.60 Mn |
| Sep 27, 2025 | 29.80 Mn |
| Sep 27, 2025 | 29.80 Mn |
| Jun 28, 2025 | 56.70 Mn |
| Jun 28, 2025 | 56.70 Mn |
| Mar 29, 2025 | -90.00 Mn |
| Mar 29, 2025 | -90.00 Mn |
| Dec 31, 2024 | 274.90 Mn |
| Dec 31, 2024 | 274.90 Mn |
| Sep 28, 2024 | 15.10 Mn |
| Sep 28, 2024 | 15.10 Mn |
| Jun 29, 2024 | -18.90 Mn |
| Jun 29, 2024 | -18.90 Mn |
| Mar 30, 2024 | -26.50 Mn |
| Mar 30, 2024 | -26.50 Mn |